ARDELYX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
ARDELYX, INC. (ARDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $68.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-02-19
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $68.10M, a 11.64% increase from fiscal 2024.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $61.00M, a 144.98% increase from fiscal 2023.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $24.90M, a 255.71% increase from fiscal 2022.
- ARDELYX, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $7.00M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $68.10M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $61.00M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $24.90M 10-K · filed 2026-02-19 | |
| 2022-12-31 | $7.00M 10-K · filed 2025-02-20 | |
| 2020-12-31 | $2.70M 10-K · filed 2021-03-08 | |
| 2019-12-31 | $400.00K 10-K · filed 2021-03-08 | |
| 2018-12-31 | $0.00 10-K · filed 2021-03-08 | |
| 2017-12-31 | $300.00K 10-K · filed 2020-03-06 | |
| 2016-12-31 | $300.00K 10-K · filed 2019-03-06 | $6.40M 10-K · filed 2017-02-17 |
| 2015-12-31 | $1.10M 10-K · filed 2018-03-14 | $2.40M 10-K · filed 2016-03-04 |
| 2014-12-31 | $500.00K 10-K · filed 2017-02-17 | |
| 2013-12-31 | $200.00K 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |